Clinical Trials Directory

Trials / Unknown

UnknownNCT03846921

Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the use of alpha-defensin as a diagnostic means to distinguish between acute bacterial and viral infections.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLaboratory blood testLaboratory blood test will be analyzed to determine whether there is a rise in alpha-defensin

Timeline

Start date
2019-03-04
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2019-02-20
Last updated
2019-03-08

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03846921. Inclusion in this directory is not an endorsement.

Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections (NCT03846921) · Clinical Trials Directory